Vivo Capital Fund IX, L.P., 10% Owner at Tarsus Pharmaceuticals, Inc. (TARS), bought 3,030,754 shares at $16.00 ($4.0M) on 2020-10-20, disclosed to the SEC on 2020-10-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,780,754 | $0 | 0.0% |
| 2 | $16.00 | 250,000 | $4.0M | 100.0% |
| Total | $1.32 avg | 3,030,754 | $4.0M | 100% |
| Filing → |
| TIL | BUY | 2021-03-25 | $6.0M | — | Filing → |